Principle-Guided Psychotherapy for Children and Adolescents (FIRST): study protocol for a randomized controlled effectiveness trial in outpatient clinics.

Anxiety Children and adolescents Conduct problems Depression Empirically supported treatment Implementation Psychotherapy Randomized controlled effectiveness trial Trauma

Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
21 Oct 2023
Historique:
received: 27 07 2023
accepted: 07 10 2023
medline: 30 10 2023
pubmed: 21 10 2023
entrez: 20 10 2023
Statut: epublish

Résumé

Hundreds of youth psychotherapy randomized trials have generated scores of helpful empirically supported treatments (ESTs). However, the standardized structure of many ESTs and their focus on a single disorder or homogeneous cluster of problems may not be ideal for clinically referred youths who have comorbidity and whose treatment needs may shift from week to week. This concern has prompted development of flexible transdiagnostic, modular youth psychotherapies. One of these, designed for efficient training and implementation, is FIRST-a transdiagnostic intervention built on five empirically supported principles of change (i.e., feeling calm, increasing motivation, repairing thoughts, solving problems, and trying the opposite) and targeting common internalizing and externalizing youth mental health disorders and problems. FIRST has shown promise in improving youth mental health in three open trials. Now, in a more rigorous test, we seek to (1) conduct a randomized controlled trial comparing FIRST to usual care in real-world clinical practice settings; (2) examine a promising candidate mediator of change-regulation of negative emotions; and (3) explore variables that may influence clinicians' treatment implementation. This is an assessor-naïve randomized controlled effectiveness trial in youth outpatient community clinics in New England and Texas. Using double randomization, clinic-employed clinicians and treatment-referred youths (7-15 years old) are independently randomly allocated (1:1) to FIRST or usual care. We aim to recruit 212 youth participants, all referred through normal community pathways, with elevated symptoms of anxiety, depression, conduct problems, or post-traumatic stress. This study will test the effectiveness of FIRST compared to usual care on mental health outcomes, examine whether those outcomes are mediated by regulation of negative emotions, and explore clinician factors that may be associated with FIRST implementation and outcomes. Session recordings are coded to assess treatment fidelity. This study will evaluate the effectiveness of FIRST in youth community mental health settings, relative to the care usually provided in those settings. If FIRST is found to be effective, it could offer an efficient and practical method to increase use of empirically supported treatment principles in real-world practice contexts. NIH Clinical Trials Registry, NCT04725721. Registered 27 January 2021, https://clinicaltrials.gov/ct2/show/study/NCT04725721.

Sections du résumé

BACKGROUND BACKGROUND
Hundreds of youth psychotherapy randomized trials have generated scores of helpful empirically supported treatments (ESTs). However, the standardized structure of many ESTs and their focus on a single disorder or homogeneous cluster of problems may not be ideal for clinically referred youths who have comorbidity and whose treatment needs may shift from week to week. This concern has prompted development of flexible transdiagnostic, modular youth psychotherapies. One of these, designed for efficient training and implementation, is FIRST-a transdiagnostic intervention built on five empirically supported principles of change (i.e., feeling calm, increasing motivation, repairing thoughts, solving problems, and trying the opposite) and targeting common internalizing and externalizing youth mental health disorders and problems. FIRST has shown promise in improving youth mental health in three open trials. Now, in a more rigorous test, we seek to (1) conduct a randomized controlled trial comparing FIRST to usual care in real-world clinical practice settings; (2) examine a promising candidate mediator of change-regulation of negative emotions; and (3) explore variables that may influence clinicians' treatment implementation.
METHODS METHODS
This is an assessor-naïve randomized controlled effectiveness trial in youth outpatient community clinics in New England and Texas. Using double randomization, clinic-employed clinicians and treatment-referred youths (7-15 years old) are independently randomly allocated (1:1) to FIRST or usual care. We aim to recruit 212 youth participants, all referred through normal community pathways, with elevated symptoms of anxiety, depression, conduct problems, or post-traumatic stress. This study will test the effectiveness of FIRST compared to usual care on mental health outcomes, examine whether those outcomes are mediated by regulation of negative emotions, and explore clinician factors that may be associated with FIRST implementation and outcomes. Session recordings are coded to assess treatment fidelity.
DISCUSSION CONCLUSIONS
This study will evaluate the effectiveness of FIRST in youth community mental health settings, relative to the care usually provided in those settings. If FIRST is found to be effective, it could offer an efficient and practical method to increase use of empirically supported treatment principles in real-world practice contexts.
TRIAL REGISTRATION BACKGROUND
NIH Clinical Trials Registry, NCT04725721. Registered 27 January 2021, https://clinicaltrials.gov/ct2/show/study/NCT04725721.

Identifiants

pubmed: 37864269
doi: 10.1186/s13063-023-07717-y
pii: 10.1186/s13063-023-07717-y
pmc: PMC10589969
doi:

Banques de données

ClinicalTrials.gov
['NCT04725721']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

682

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH124965
Pays : United States
Organisme : NIMH NIH HHS
ID : 5R01MH124965
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Adm Policy Ment Health. 2012 Mar;39(1-2):78-89
pubmed: 22407555
Am Psychol. 2017 Feb-Mar;72(2):79-117
pubmed: 28221063
Ment Health Serv Res. 2001 Jun;3(2):73-89
pubmed: 12109840
J Clin Psychol. 2006 Jun;62(6):631-8
pubmed: 16538667
Behav Modif. 2003 Jul;27(3):300-12
pubmed: 12841586
Adm Policy Ment Health. 2012 Mar;39(1-2):3-12
pubmed: 22421933
Behav Res Ther. 2013 Oct;51(10):706-10
pubmed: 23973815
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
J Evid Based Soc Work. 2013 Oct;10(5):396-409
pubmed: 24066630
J Clin Child Adolesc Psychol. 2017 Jan-Feb;46(1):44-58
pubmed: 27442352
J Clin Child Adolesc Psychol. 2020 Nov-Dec;49(6):883-896
pubmed: 31517543
Am Psychol. 2006 Oct;61(7):671-89
pubmed: 17032068
JAMA Netw Open. 2020 Aug 3;3(8):e2011799
pubmed: 32804212
Adm Policy Ment Health. 2020 Jul;47(4):581-596
pubmed: 32076887
J Consult Clin Psychol. 2017 Jan;85(1):13-25
pubmed: 27548030
Annu Rev Clin Psychol. 2007;3:1-27
pubmed: 17716046
Am J Psychiatry. 2005 Mar;162(3):530-7
pubmed: 15741470
J Consult Clin Psychol. 2005 Apr;73(2):323-33
pubmed: 15796640
Child Psychiatry Hum Dev. 2020 Oct;51(5):709-720
pubmed: 32157488
J Consult Clin Psychol. 2013 Dec;81(6):999-1009
pubmed: 23978169
J Clin Psychiatry. 2010 Mar;71(3):313-26
pubmed: 20331933
J Consult Clin Psychol. 1994 Oct;62(5):1069-74
pubmed: 7806717
Psychiatr Serv. 2004 Sep;55(9):1022-8
pubmed: 15345762
Behav Modif. 2009 Jan;33(1):48-65
pubmed: 18723838
Br J Psychiatry. 1993 Aug;163:239-47
pubmed: 8075917
J Child Psychol Psychiatry. 2017 Sep;58(9):970-984
pubmed: 28548291
Arch Gen Psychiatry. 2012 Mar;69(3):274-82
pubmed: 22065252
JAMA Psychiatry. 2013 Jul;70(7):750-61
pubmed: 23754332
Arch Gen Psychiatry. 1987 Dec;44(12):1057-63
pubmed: 3689093
Eur Child Adolesc Psychiatry. 2004;13 Suppl 2:II25-31
pubmed: 15243783
Implement Sci. 2016 May 05;11:60
pubmed: 27150798
J Clin Child Adolesc Psychol. 2020 Nov-Dec;49(6):737-751
pubmed: 30657721
J Emot Behav Disord. 2013 Mar 1;21(1):18-32
pubmed: 23997569
Adm Policy Ment Health. 2017 Mar;44(2):269-283
pubmed: 27236457
J Clin Child Adolesc Psychol. 2005 Mar;34(1):117-28
pubmed: 15677286
Behav Res Ther. 2017 Dec;99:1-10
pubmed: 28865284
J Am Acad Child Adolesc Psychiatry. 2004 Nov;43(11):1345-54
pubmed: 15502593
Curr Psychiatry Rep. 2004 Apr;6(2):96-100
pubmed: 15038911
J Am Acad Child Adolesc Psychiatry. 2004 Nov;43(11):1334-44
pubmed: 15502592
Adm Policy Ment Health. 2014 May;41(3):353-9
pubmed: 23377768
J Consult Clin Psychol. 2011 Jun;79(3):369-80
pubmed: 21500888
Ment Health Serv Res. 2004 Jun;6(2):61-74
pubmed: 15224451
J Consult Clin Psychol. 2015 Aug;83(4):709-18
pubmed: 25984802
Clin Psychol Sci. 2019 Jan;7(1):37-50
pubmed: 30713811

Auteurs

Abby Bailin (A)

Department of Educational Psychology, The University of Texas at Austin, 1912 Speedway, Suite 5.708, Austin, TX, 78712-1289, USA. abby.bailin@utexas.edu.

Evelyn Cho (E)

Department of Psychology, Harvard University, 33 Kirkland Street, Cambridge, MA, 02318, USA.

Ariel Sternberg (A)

Department of Psychology, Harvard University, 33 Kirkland Street, Cambridge, MA, 02318, USA.

Spencer C Evans (SC)

University of Miami, 5665 Ponce de Leon Blvd, Coral Gables, FL, 33146, USA.

Nathan L Hollinsaid (NL)

Department of Psychology, Harvard University, 33 Kirkland Street, Cambridge, MA, 02318, USA.

Sarah Kate Bearman (SK)

Department of Educational Psychology, The University of Texas at Austin, 1912 Speedway, Suite 5.708, Austin, TX, 78712-1289, USA.

John R Weisz (JR)

Department of Psychology, Harvard University, 33 Kirkland Street, Cambridge, MA, 02318, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH